Belvedere Trading LLC Aurinia Pharmaceuticals Inc. Put Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 09, 2024
SELL
$4.93 - $9.31 $19,227 - $36,309
-3,900 Reduced 36.79%
6,700 $33,000
Q4 2023

Feb 13, 2024
BUY
$7.13 - $9.49 $42,067 - $55,991
5,900 Added 125.53%
10,600 $95,000
Q3 2023

Oct 27, 2023
BUY
$7.77 - $12.27 $19,425 - $30,675
2,500 Added 113.64%
4,700 $36,000
Q2 2023

Aug 08, 2023
SELL
$8.96 - $11.69 $2,688 - $3,507
-300 Reduced 12.0%
2,200 $21,000
Q4 2022

Feb 14, 2023
BUY
$4.11 - $8.14 $10,275 - $20,350
2,500 New
2,500 $10,000

Others Institutions Holding AUPH

# of Institutions
209
Shares Held
58.7M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email